Natural-origin original molecules
Explore original drug opportunities through natural scaffolds, mechanisms and optimization potential.
INVESTORS / LONG-TERM INNOVATIONBuild an R&D advantage with AI.
Build an R&D advantage with AI.
Create lasting value through original medicines.
Veritas connects AI and experimental research to incubate original medicines, building drug assets around differentiated candidates, testable mechanisms and intellectual property. Custom R&D links industry needs with platform refinement. Key milestones guide assessments of development risk and resource allocation, while joint development and licensing offer paths to realizing value.
Where we see innovation value
Global botanical drugs
Identify botanical candidates for defined modern medical indications using AI, then investigate pharmacology, safety and consistency under target-market requirements.
Innovative TCM drugs
Focus on China’s Classes 1.1, 1.2 and 1.3, connecting TCM theory, human-use experience and clinical research.
AI across the lifecycle
Connect selection, experimental feedback and resources through traceable program knowledge.
Two engines, one synergistic business model
Investor dialogue
Discussions can address strategy, milestones, key risks, rights and resource needs.
Investor enquiries ↗